Importantly, in ARDS the inadequate GRα-mediated downregulation of pro-inflammatory transcription factor NF-κB in circulating and tissue cells leads to persistent elevation over time (>4 weeks) in plasma and BAL markers of inflammation, hemostasis, and tissue repair (maladaptive repair) (1). This evidence concerns the gene NFKB1 and acute respiratory distress syndrome.